nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Accuracy of the Third Generation of a 14-Day Continuous Glucose Monitoring System
|
Alva, Shridhara |
|
|
14 |
4 |
p. 767-776 |
artikel |
2 |
A Randomized, Placebo-Controlled Crossover Study to Evaluate Postprandial Glucometabolic Effects of Mulberry Leaf Extract, Vitamin D, Chromium, and Fiber in People with Type 2 Diabetes
|
Mohamed, Mafauzy |
|
|
14 |
4 |
p. 749-766 |
artikel |
3 |
Correction to: Addendum 1: Forum for Injection Technique and Therapy Expert Recommendations, India
|
Kalra, Sanjay |
|
|
14 |
4 |
p. 787 |
artikel |
4 |
Development and Validation of a Distress Measurement Related to Glucose Monitoring of Diabetes Patients
|
Choi, Eujin |
|
|
14 |
4 |
p. 737-748 |
artikel |
5 |
Effectiveness and Safety of iGlarLixi (Insulin Glargine 100 U/mL Plus Lixisenatide) in Type 2 Diabetes According to the Timing of Daily Administration: Data from the REALI Pooled Analysis
|
Haluzík, Martin |
|
|
14 |
4 |
p. 639-652 |
artikel |
6 |
GLP-1 Receptor Agonists Induce Growth Hormone Secretion in Healthy Volunteers
|
Heinla, Keiu |
|
|
14 |
4 |
p. 777-786 |
artikel |
7 |
Impact of Type 2 Diabetes Duration on the Efficacy and Safety of Add-on Lixisenatide in Asian Individuals Receiving Basal Insulin: A Pooled Analysis
|
Yao, Jun |
|
|
14 |
4 |
p. 653-669 |
artikel |
8 |
Living with Type 2 Diabetes: Podcast of a Patient–Physician Discussion
|
Kushner, Pamela |
|
|
14 |
4 |
p. 621-627 |
artikel |
9 |
Malignant External Otitis: What the Diabetes Specialist Should Know—A Narrative Review
|
Tsilivigkos, Christos |
|
|
14 |
4 |
p. 629-638 |
artikel |
10 |
Real-World Evaluation of GLP-1 Receptor Agonist Therapy Persistence, Adherence and Therapeutic Inertia Among Obese Adults with Type 2 Diabetes
|
Palanca, Ana |
|
|
14 |
4 |
p. 723-736 |
artikel |
11 |
The Association Between Obesity and the 5-Year Prevalence of Morbidity and Mortality Among Adults with Type 2 Diabetes
|
Boye, Kristina S. |
|
|
14 |
4 |
p. 709-721 |
artikel |
12 |
The Effect of the COVID-19 Pandemic on HbA1c Testing: Prioritization of High-Risk Cases and Impact of Social Deprivation
|
Holland, David |
|
|
14 |
4 |
p. 691-707 |
artikel |
13 |
Use of iGlarLixi for the Management of Type 2 Diabetes in Japanese Clinical Practice: Prior Treatment Subgroup Analysis of the SPARTA Japan Study
|
Miyoshi, Hideaki |
|
|
14 |
4 |
p. 671-689 |
artikel |